Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001240612 | SCV001413577 | uncertain significance | Glucose-6-phosphate transport defect | 2019-04-03 | criteria provided, single submitter | clinical testing | This sequence change replaces glutamic acid with glycine at codon 254 of the SLC37A4 protein (p.Glu254Gly). The glutamic acid residue is highly conserved and there is a moderate physicochemical difference between glutamic acid and glycine. This variant is present in population databases (rs781834348, ExAC 0.003%). This variant has not been reported in the literature in individuals with SLC37A4-related disease. Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C15"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Fulgent Genetics, |
RCV002484317 | SCV002777027 | uncertain significance | Phosphate transport defect; Glucose-6-phosphate transport defect; Congenital disorder of glycosylation, type IIw | 2022-01-12 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001240612 | SCV002078740 | uncertain significance | Glucose-6-phosphate transport defect | 2020-04-28 | no assertion criteria provided | clinical testing |